Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Phosphatase 1 | 12 | 2025 | 70 | 2.270 |
Why?
|
| Virus Replication | 12 | 2025 | 318 | 1.490 |
Why?
|
| Ebolavirus | 5 | 2025 | 49 | 1.170 |
Why?
|
| HIV-1 | 9 | 2022 | 755 | 1.040 |
Why?
|
| Transcription, Genetic | 8 | 2022 | 592 | 0.850 |
Why?
|
| Cyclin-Dependent Kinase 9 | 4 | 2018 | 37 | 0.800 |
Why?
|
| Antiviral Agents | 3 | 2018 | 195 | 0.630 |
Why?
|
| Viral Proteins | 7 | 2025 | 190 | 0.570 |
Why?
|
| Phosphorylation | 12 | 2024 | 986 | 0.500 |
Why?
|
| Serine | 3 | 2018 | 79 | 0.500 |
Why?
|
| Polycythemia | 5 | 2017 | 15 | 0.470 |
Why?
|
| Anemia, Sickle Cell | 4 | 2021 | 187 | 0.410 |
Why?
|
| Anti-HIV Agents | 3 | 2015 | 486 | 0.410 |
Why?
|
| RNA-Binding Proteins | 3 | 2012 | 161 | 0.400 |
Why?
|
| Gene Expression Regulation, Viral | 4 | 2019 | 113 | 0.400 |
Why?
|
| Nucleoproteins | 2 | 2025 | 15 | 0.380 |
Why?
|
| Biocatalysis | 1 | 2012 | 30 | 0.370 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 62 | 0.360 |
Why?
|
| Capsid | 2 | 2025 | 65 | 0.350 |
Why?
|
| Rift Valley fever virus | 2 | 2024 | 9 | 0.330 |
Why?
|
| Endoribonucleases | 1 | 2010 | 25 | 0.330 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2010 | 49 | 0.330 |
Why?
|
| RNA, Viral | 7 | 2024 | 321 | 0.320 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 2018 | 55 | 0.300 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 5 | 2017 | 20 | 0.290 |
Why?
|
| Erythropoietin | 4 | 2016 | 38 | 0.240 |
Why?
|
| Cell Line | 6 | 2024 | 1410 | 0.240 |
Why?
|
| Vero Cells | 6 | 2024 | 112 | 0.220 |
Why?
|
| Protein Multimerization | 1 | 2025 | 115 | 0.210 |
Why?
|
| Transcription Factors | 3 | 2019 | 735 | 0.210 |
Why?
|
| Hydroxyurea | 2 | 2016 | 34 | 0.200 |
Why?
|
| Protein Binding | 6 | 2025 | 1082 | 0.200 |
Why?
|
| Humans | 26 | 2025 | 43102 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 200 | 0.180 |
Why?
|
| Sickle Cell Trait | 1 | 2021 | 19 | 0.180 |
Why?
|
| Amino Acid Sequence | 3 | 2018 | 1180 | 0.180 |
Why?
|
| Animals | 11 | 2025 | 16992 | 0.170 |
Why?
|
| Drug Stability | 2 | 2018 | 129 | 0.170 |
Why?
|
| Catalytic Domain | 2 | 2018 | 118 | 0.160 |
Why?
|
| Viral Core Proteins | 1 | 2019 | 12 | 0.160 |
Why?
|
| Urea | 2 | 2019 | 46 | 0.160 |
Why?
|
| Lymphopenia | 1 | 2019 | 17 | 0.150 |
Why?
|
| Mass Spectrometry | 2 | 2011 | 280 | 0.150 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2019 | 33 | 0.150 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1542 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2017 | 88 | 0.140 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2018 | 11 | 0.140 |
Why?
|
| Indoles | 2 | 2019 | 187 | 0.140 |
Why?
|
| Capsid Proteins | 1 | 2018 | 76 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 279 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2018 | 32 | 0.130 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2017 | 3 | 0.130 |
Why?
|
| Methemoglobinemia | 1 | 2017 | 2 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2016 | 2 | 0.130 |
Why?
|
| Thrombospondin 1 | 1 | 2017 | 23 | 0.130 |
Why?
|
| Thrombosis | 1 | 2017 | 81 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2018 | 1621 | 0.120 |
Why?
|
| Models, Molecular | 3 | 2018 | 876 | 0.120 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 386 | 0.120 |
Why?
|
| HIV Infections | 2 | 2021 | 2586 | 0.120 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 75 | 0.120 |
Why?
|
| Homozygote | 3 | 2013 | 77 | 0.120 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2015 | 57 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2021 | 247 | 0.110 |
Why?
|
| DNA Replication | 1 | 2016 | 148 | 0.110 |
Why?
|
| Antisickling Agents | 2 | 2016 | 14 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2014 | 12 | 0.110 |
Why?
|
| Streptomycin | 1 | 2013 | 4 | 0.100 |
Why?
|
| Curcumin | 1 | 2015 | 118 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1070 | 0.100 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 31 | 0.100 |
Why?
|
| Gene Expression | 1 | 2017 | 701 | 0.100 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2013 | 20 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 462 | 0.100 |
Why?
|
| Mutation | 3 | 2018 | 1177 | 0.100 |
Why?
|
| Mice | 3 | 2022 | 6644 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 78 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 333 | 0.100 |
Why?
|
| Intracellular Space | 1 | 2012 | 37 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 97 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 3 | 2019 | 209 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 863 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 561 | 0.090 |
Why?
|
| Iron | 1 | 2013 | 251 | 0.090 |
Why?
|
| Protein Transport | 1 | 2012 | 296 | 0.090 |
Why?
|
| Peptide Mapping | 1 | 2011 | 20 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 38 | 0.090 |
Why?
|
| Point Mutation | 2 | 2009 | 98 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 197 | 0.080 |
Why?
|
| Threonine | 1 | 2010 | 24 | 0.080 |
Why?
|
| Gene Products, tat | 1 | 2010 | 36 | 0.080 |
Why?
|
| Rift Valley Fever | 2 | 2024 | 8 | 0.080 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 31 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 671 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2012 | 383 | 0.080 |
Why?
|
| Rabbits | 1 | 2010 | 278 | 0.080 |
Why?
|
| Genome, Viral | 2 | 2024 | 119 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 432 | 0.080 |
Why?
|
| Fetal Hemoglobin | 1 | 2009 | 13 | 0.080 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2009 | 12 | 0.080 |
Why?
|
| Peptides | 1 | 2012 | 372 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 595 | 0.070 |
Why?
|
| CDC2 Protein Kinase | 1 | 2008 | 19 | 0.070 |
Why?
|
| RNA Splicing | 1 | 2008 | 41 | 0.070 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 12 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1271 | 0.070 |
Why?
|
| Homocysteine | 1 | 2008 | 21 | 0.070 |
Why?
|
| Dipeptides | 1 | 2008 | 31 | 0.070 |
Why?
|
| Glutathione | 1 | 2008 | 171 | 0.060 |
Why?
|
| Female | 9 | 2021 | 24698 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 436 | 0.060 |
Why?
|
| RNA Interference | 2 | 2019 | 247 | 0.060 |
Why?
|
| Cytokines | 1 | 2009 | 678 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2018 | 416 | 0.050 |
Why?
|
| Casein Kinase Ialpha | 1 | 2024 | 2 | 0.050 |
Why?
|
| Male | 8 | 2017 | 23409 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2022 | 42 | 0.050 |
Why?
|
| Cell Hypoxia | 2 | 2014 | 60 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 216 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1285 | 0.040 |
Why?
|
| Russia | 2 | 2011 | 29 | 0.040 |
Why?
|
| Nucleocapsid Proteins | 1 | 2019 | 12 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 87 | 0.040 |
Why?
|
| Child | 3 | 2017 | 3443 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 31 | 0.040 |
Why?
|
| Viral Matrix Proteins | 1 | 2019 | 18 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2019 | 48 | 0.040 |
Why?
|
| Chiroptera | 1 | 2019 | 25 | 0.040 |
Why?
|
| Virion | 1 | 2019 | 75 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 127 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2017 | 1546 | 0.040 |
Why?
|
| Adult | 5 | 2017 | 13872 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2019 | 91 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 11 | 0.040 |
Why?
|
| Cyclin T | 1 | 2018 | 16 | 0.040 |
Why?
|
| Autophagy | 1 | 2019 | 140 | 0.040 |
Why?
|
| Hela Cells | 2 | 2010 | 376 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 62 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 189 | 0.030 |
Why?
|
| Methemoglobin | 1 | 2017 | 3 | 0.030 |
Why?
|
| Siberia | 1 | 2017 | 4 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 2017 | 11 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 378 | 0.030 |
Why?
|
| Adolescent | 3 | 2017 | 6081 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 113 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 94 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 118 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 52 | 0.030 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2015 | 35 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 63 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 52 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 518 | 0.030 |
Why?
|
| Virulence | 1 | 2016 | 246 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 712 | 0.030 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2014 | 22 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 532 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 861 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1067 | 0.030 |
Why?
|
| Streptomyces | 1 | 2013 | 22 | 0.030 |
Why?
|
| Phlebotomy | 1 | 2013 | 5 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1078 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 863 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 88 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 48 | 0.030 |
Why?
|
| Middle Aged | 3 | 2017 | 12222 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 166 | 0.020 |
Why?
|
| Infant | 1 | 2017 | 1175 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 90 | 0.020 |
Why?
|
| Sex Factors | 1 | 2017 | 1028 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2013 | 245 | 0.020 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2012 | 15 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 704 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2013 | 171 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1124 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 518 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 695 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 1612 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 154 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 258 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 465 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 389 | 0.020 |
Why?
|
| Ferritins | 1 | 2011 | 63 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2013 | 460 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 51 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2853 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 2544 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 423 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 456 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1600 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1759 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2009 | 29 | 0.020 |
Why?
|
| Interleukins | 1 | 2009 | 40 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 92 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 758 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2008 | 9 | 0.020 |
Why?
|
| Young Adult | 2 | 2009 | 5080 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 183 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 384 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 800 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1568 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2008 | 666 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 2157 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 8214 | 0.010 |
Why?
|